Total Payments
$5,072
2024 Payments
$988.53
Companies
12
Transactions
95
Medicare Patients
1,294
Medicare Billing
$272,302
Payment Breakdown by Category
Food & Beverage$5,006 (98.7%)
Education$66.26 (1.3%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,006 | 91 | 98.7% |
| Education | $66.26 | 4 | 1.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Alkermes, Inc. | $1,573 | 18 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $776.84 | 16 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $600.08 | 12 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $490.04 | 22 | $0 (2019) |
| Teva Pharmaceuticals USA, Inc. | $402.76 | 10 | $0 (2024) |
| Allergan, Inc. | $301.76 | 5 | $0 (2020) |
| E.R. Squibb & Sons, L.L.C. | $246.83 | 2 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $232.68 | 2 | $0 (2024) |
| ABBVIE INC. | $150.39 | 2 | $0 (2022) |
| Avanir Pharmaceuticals, Inc. | $114.74 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $988.53 | 18 | Teva Pharmaceuticals USA, Inc. ($338.70) |
| 2023 | $390.79 | 10 | Otsuka America Pharmaceutical, Inc. ($163.49) |
| 2022 | $133.14 | 4 | ABBVIE INC. ($74.20) |
| 2021 | $432.32 | 6 | Alkermes, Inc. ($249.59) |
| 2020 | $504.76 | 7 | Alkermes, Inc. ($331.66) |
| 2019 | $747.45 | 11 | Janssen Pharmaceuticals, Inc ($245.49) |
| 2018 | $861.81 | 16 | Alkermes, Inc. ($307.20) |
| 2017 | $1,013 | 23 | Sunovion Pharmaceuticals Inc. ($331.42) |
All Payment Transactions
95 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/04/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $129.90 | General |
| Category: Neuropsychiatry | ||||||
| 11/20/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $121.83 | General |
| Category: Psychiatry/Psychology | ||||||
| 10/22/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $107.17 | General |
| Category: Neurology | ||||||
| 10/01/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $22.02 | General |
| Category: Neuroscience | ||||||
| 09/26/2024 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $125.00 | General |
| 08/02/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $15.38 | General |
| Category: Neurology | ||||||
| 07/16/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $13.20 | General |
| Category: Central Nervous System | ||||||
| 06/27/2024 | Indivior Inc. | PERSERIS (Drug) | Food and Beverage | In-kind items and services | $35.97 | General |
| Category: BH | ||||||
| 06/25/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $29.65 | General |
| Category: Neuroscience | ||||||
| 05/22/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $28.02 | General |
| Category: Neurology | ||||||
| 05/07/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), ABILIFY ASIMTUFII | Food and Beverage | In-kind items and services | $16.72 | General |
| Category: PSYCHIATRY | ||||||
| 04/24/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $115.00 | General |
| Category: Neurology | ||||||
| 04/17/2024 | Indivior Inc. | PERSERIS (Drug) | Food and Beverage | In-kind items and services | $27.13 | General |
| Category: BH | ||||||
| 03/27/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $27.29 | General |
| Category: Neurology | ||||||
| 03/19/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $17.80 | General |
| Category: Neuroscience | ||||||
| 02/29/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY ASIMTUFII (Drug) | Food and Beverage | In-kind items and services | $20.53 | General |
| Category: PSYCHIATRY | ||||||
| 01/31/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $103.28 | General |
| Category: Neuroscience | ||||||
| 01/31/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $32.64 | General |
| Category: Central Nervous System | ||||||
| 12/20/2023 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $11.43 | General |
| Category: Neuroscience | ||||||
| 11/28/2023 | Indivior Inc. | PERSERIS (Drug) | Food and Beverage | In-kind items and services | $15.83 | General |
| Category: BH | ||||||
| 11/14/2023 | Otsuka America Pharmaceutical, Inc. | ABILIFY ASIMTUFII (Drug), ABILIFY MAINTENA | Food and Beverage | In-kind items and services | $22.41 | General |
| Category: PSYCHIATRY | ||||||
| 10/25/2023 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $14.67 | General |
| Category: Central Nervous System | ||||||
| 09/27/2023 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Food and Beverage | In-kind items and services | $115.00 | General |
| Category: CNS | ||||||
| 09/26/2023 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $28.77 | General |
| Category: Neurology | ||||||
| 08/01/2023 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $20.98 | General |
| Category: CNS | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 430 | 2,435 | $325,970 | $106,949 |
| 2022 | 3 | 253 | 1,364 | $175,480 | $46,658 |
| 2021 | 3 | 327 | 1,692 | $214,154 | $58,219 |
| 2020 | 3 | 284 | 1,685 | $249,540 | $60,476 |
Total Patients
1,294
Total Services
7,176
Medicare Billing
$272,302
Procedure Codes
13
All Medicare Procedures & Services
13 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 286 | 2,280 | $289,065 | $92,518 | 32.0% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Facility | 2023 | 61 | 62 | $21,080 | $8,362 | 39.7% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 46 | 51 | $9,945 | $3,251 | 32.7% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 37 | 42 | $5,880 | $2,818 | 47.9% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 205 | 1,315 | $162,985 | $41,025 | 25.2% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Facility | 2022 | 27 | 28 | $8,400 | $4,004 | 47.7% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 21 | 21 | $4,095 | $1,630 | 39.8% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 278 | 1,641 | $201,996 | $52,142 | 25.8% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Facility | 2021 | 30 | 32 | $8,320 | $4,598 | 55.3% |
| 99221 | Initial hospital inpatient care, typically 30 minutes per day | Facility | 2021 | 19 | 19 | $3,838 | $1,479 | 38.5% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2020 | 212 | 1,612 | $235,055 | $53,687 | 22.8% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Facility | 2020 | 41 | 42 | $10,920 | $4,865 | 44.5% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2020 | 31 | 31 | $3,565 | $1,924 | 54.0% |
About Dr. Anil Rai, MD
Dr. Anil Rai, MD is a Psychiatry healthcare provider based in Kingston, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/01/2005. The National Provider Identifier (NPI) number assigned to this provider is 1306830658.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Anil Rai, MD has received a total of $5,072 in payments from pharmaceutical and medical device companies, with $988.53 received in 2024. These payments were reported across 95 transactions from 12 companies. The most common payment nature is "Food and Beverage" ($5,006).
As a Medicare-enrolled provider, Rai has provided services to 1,294 Medicare beneficiaries, totaling 7,176 services with total Medicare billing of $272,302. Data is available for 4 years (2020–2023), covering 13 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatry
- Location Kingston, PA
- Active Since 09/01/2005
- Last Updated 07/08/2007
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1306830658
Products in Payments
- ARISTADA (Drug) $832.86
- Aristada 441 mg (Drug) $624.85
- INVEGA SUSTENNA (Drug) $624.51
- LATUDA (Drug) $490.04
- ABILIFY MAINTENA (Drug) $453.40
- VRAYLAR (Drug) $452.15
- UZEDY (Drug) $321.63
- INGREZZA (Drug) $232.68
- INVEGA TRINZA (Drug) $127.26
- COBENFY (Drug) $121.83
- LYBALVI (Drug) $115.00
- NUEDEXTA (Drug) $114.74
- CAPLYTA (Drug) $104.16
- REXULTI (Drug) $103.74
- Austedo XR (Drug) $81.13
- PERSERIS (Drug) $78.93
- ABILIFY ASIMTUFII (Drug) $42.94
- SPRAVATO (Drug) $20.52
- INVEGA (Drug) $4.55
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Kingston
Dr. Jane Jesse, Md, MD
Psychiatry — Payments: $539,854
Psychiatry $539,854
Dr. Mark Saxon, D.o, D.O
Psychiatry — Payments: $40,313
Psychiatry $40,313
Dr. Richard Fischbein, Md, MD
Psychiatry — Payments: $4,135
Psychiatry $4,135
Dal Sperazza, M.d, M.D
Psychiatry — Payments: $3,545
Psychiatry $3,545
Dr. Md.mushfiqur Rahman, M.d, M.D
Psychiatry — Payments: $2,313
Psychiatry $2,313
Dr. Julita Andrew, M.d, M.D
Psychiatry — Payments: $2,144
Psychiatry $2,144